Literature DB >> 8432607

Murine peritoneal macrophages activated by the mycobacterial 65-kilodalton heat shock protein express enhanced microbicidal activity in vitro.

W E Peetermans1, J A Langermans, M E van der Hulst, J D van Embden, R van Furth.   

Abstract

After an intraperitoneal (i.p.) injection of purified protein derivative, peritoneal macrophages from mice infected with Mycobacterium bovis bacillus Calmette-Guérin (BCG) show an enhanced respiratory burst, inhibit the intracellular proliferation of Toxoplasma gondii, and kill Listeria monocytogenes more efficiently than peritoneal macrophages from normal mice. One of the immunodominant antigens of Mycobacterium spp. is the 65-kDa heat shock protein (Hsp 65), and in the present study, we determined whether injection of this protein into mice leads to activation of their peritoneal macrophages. After an i.p. injection of Hsp 65, peritoneal macrophages from BCG-infected CBA/J mice also released more H2O2, inhibited the proliferation of T. gondii, and killed L. monocytogenes faster than peritoneal macrophages from normal mice, although Hsp 65 was less effective than purified protein derivative. When normal mice were injected with Hsp 65 suspended in saline after a booster injection with Hsp 65, their macrophages did not display enhanced antimicrobial activity, indicating that an adjuvant was required for a cellular immune response against Hsp 65. In the present study, the adjuvant dimethyl dioctadecylammonium bromide (DDA) was preferred because it contains no endotoxin or mycobacterial antigens and because it has been reported that DDA does not induce the production of gamma interferon. Peritoneal macrophages from C57BL/6 and CBA/J mice that had received a subcutaneous injection of Hsp 65 suspended in DDA followed by an i.p. booster injection of Hsp 65 suspended in saline were activated, as indicated by the enhanced production of H2O2, inhibition of the intracellular proliferation of T. gondii, and increased rate of intracellular killing of L. monocytogenes in vitro relative to that by resident peritoneal macrophages and peritoneal macrophages obtained from mice that had received ovalbumin instead of Hsp 65. The rate of phagocytosis of L. monocytogenes was not affected by Hsp 65 treatment. Despite the in vitro expression of enhanced microbicidal activity of peritoneal macrophages, no difference in the growth of L. monocytogenes in the liver and spleen between Hsp 65-treated and control mice was found.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8432607      PMCID: PMC302813          DOI: 10.1128/iai.61.3.868-875.1993

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  43 in total

Review 1.  Biochemical criteria for activated macrophages.

Authors:  M L Karnovsky; J K Lazdins
Journal:  J Immunol       Date:  1978-09       Impact factor: 5.422

2.  Induction and therapy of autoimmune diabetes in the non-obese diabetic (NOD/Lt) mouse by a 65-kDa heat shock protein.

Authors:  D Elias; D Markovits; T Reshef; R van der Zee; I R Cohen
Journal:  Proc Natl Acad Sci U S A       Date:  1990-02       Impact factor: 11.205

3.  Resistance and susceptibility of mice to bacterial infection: genetics of listeriosis.

Authors:  C Cheers; I F McKenzie
Journal:  Infect Immun       Date:  1978-03       Impact factor: 3.441

4.  Dimethyl diotadecyl ammonium bromide as adjuvant for delayed hypersensitivity in mice.

Authors:  H Snippe; M Belder; J M Willers
Journal:  Immunology       Date:  1977-12       Impact factor: 7.397

5.  Induction of Salmonella stress proteins upon infection of macrophages.

Authors:  N A Buchmeier; F Heffron
Journal:  Science       Date:  1990-05-11       Impact factor: 47.728

6.  Recognition of a mycobacteria-specific epitope in the 65-kD heat-shock protein by synovial fluid-derived T cell clones.

Authors:  J S Gaston; P F Life; P J Jenner; M J Colston; P A Bacon
Journal:  J Exp Med       Date:  1990-03-01       Impact factor: 14.307

7.  Macrophage oxygen-dependent antimicrobial activity. III. Enhanced oxidative metabolism as an expression of macrophage activation.

Authors:  H W Murray; Z A Cohn
Journal:  J Exp Med       Date:  1980-12-01       Impact factor: 14.307

8.  The origin and kinetics of mononuclear phagocytes.

Authors:  R van Furth; Z A Cohn
Journal:  J Exp Med       Date:  1968-09-01       Impact factor: 14.307

9.  THE IMMUNOLOGICAL BASIS OF ACQUIRED CELLULAR RESISTANCE.

Authors:  G B MACKANESS
Journal:  J Exp Med       Date:  1964-07-01       Impact factor: 14.307

10.  Interactions between rabbit polymorphonuclear leucocytes and staphylococci.

Authors:  Z A COHN; S I MORSE
Journal:  J Exp Med       Date:  1959-09-01       Impact factor: 14.307

View more
  5 in total

1.  Immunological response to the Brucella abortus GroEL homolog.

Authors:  J Lin; L G Adams; T A Ficht
Journal:  Infect Immun       Date:  1996-10       Impact factor: 3.441

2.  Mycobacterium tuberculosis chaperonin 60.1 is a more potent cytokine stimulator than chaperonin 60.2 (Hsp 65) and contains a CD14-binding domain.

Authors:  J C Lewthwaite; A R Coates; P Tormay; M Singh; P Mascagni; S Poole; M Roberts; L Sharp; B Henderson
Journal:  Infect Immun       Date:  2001-12       Impact factor: 3.441

3.  Mycobacterial 65-kilodalton heat shock protein induces tumor necrosis factor alpha and interleukin 6, reactive nitrogen intermediates, and toxoplasmastatic activity in murine peritoneal macrophages.

Authors:  W E Peetermans; C J Raats; R van Furth; J A Langermans
Journal:  Infect Immun       Date:  1995-09       Impact factor: 3.441

4.  A Mycobacterium tuberculosis mutant lacking the groEL homologue cpn60.1 is viable but fails to induce an inflammatory response in animal models of infection.

Authors:  Yanmin Hu; Brian Henderson; Peter A Lund; Peter Tormay; M Tabish Ahmed; Sudagar S Gurcha; Gurdyal S Besra; Anthony R M Coates
Journal:  Infect Immun       Date:  2008-01-28       Impact factor: 3.441

Review 5.  Heat shock proteins: stimulators of innate and acquired immunity.

Authors:  Camilo A Colaco; Christopher R Bailey; K Barry Walker; James Keeble
Journal:  Biomed Res Int       Date:  2013-05-25       Impact factor: 3.411

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.